Jayakumar Devachandran, Ramachandran Dnb Pratheema, Rabindrarajan Dnb Ebenezer, Vijayaraghavan Md Bharath Kumar Tirupakuzhi, Ramakrishnan Ab Nagarajan, Venkataraman Ab Ramesh
Department of Critical Care Medicine, 343134Apollo Speciality Hospital OMR, Chennai, Tamilnadu, India.
Department of Critical Care Medicine, Apollo Speciality Hospital Vanagaram, Chennai, Tamilnadu, India.
J Intensive Care Med. 2021 Aug;36(8):918-924. doi: 10.1177/08850666211014480. Epub 2021 May 5.
The feasibility and safety of awake prone positioning and its impact on outcomes in non-intubated patients with acute respiratory distress syndrome secondary to COVID-19 is unknown. Results of the observational studies published during this pandemic have been conflicting. In this context, we conducted a multi-center, parallel group, randomized controlled feasibility study on awake prone positioning in non-intubated patients with COVID-19 pneumonia requiring supplemental oxygen.
60 patients with acute hypoxic respiratory failure secondary to COVID-19 pneumonia requiring 4 or more liters of oxygen to maintain a saturation of ≥92% were recruited in this study. Thirty patients each were randomized to either standard care or awake prone group. Patients randomized to the prone group were encouraged to self-prone for at least 6 hours a day. The primary outcome was the proportion of patients adhering to the protocol in each group.
In the prone group, 43% (13 out of 30) of patients were able to self-prone for 6 or more hours a day. In the supine group, 47% (14 out of 30) were completely supine and 53% spent some hours in the prone position, but none exceeded 6 hours. There was no significant difference in any of the secondary outcomes between the 2 groups and there were no adverse events.
Awake prone positioning in non-intubated patients with acute hypoxic respiratory failure is feasible and safe under clinical trial conditions. The results of our feasibility study will potentially help in the design of larger definitive trials to address this key knowledge gap.
清醒俯卧位通气在新型冠状病毒肺炎继发急性呼吸窘迫综合征的非插管患者中的可行性、安全性及其对预后的影响尚不清楚。在此次疫情期间发表的观察性研究结果相互矛盾。在此背景下,我们对需要补充氧气的新型冠状病毒肺炎非插管患者进行了一项多中心、平行组、随机对照可行性研究,以探讨清醒俯卧位通气的效果。
本研究招募了60例因新型冠状病毒肺炎继发急性低氧性呼吸衰竭、需要4升或更多氧气以维持血氧饱和度≥92%的患者。每组30例患者被随机分为标准治疗组或清醒俯卧位组。随机分配到俯卧位组的患者被鼓励每天自行俯卧至少6小时。主要结局是每组中遵守方案的患者比例。
在俯卧位组中,43%(30例中的13例)的患者能够每天自行俯卧6小时或更长时间。在仰卧位组中,47%(30例中的14例)完全仰卧,53%的患者有一段时间处于俯卧位,但无人超过6小时。两组之间的任何次要结局均无显著差异,且无不良事件发生。
在临床试验条件下,清醒俯卧位通气在急性低氧性呼吸衰竭的非插管患者中是可行且安全的。我们的可行性研究结果可能有助于设计更大规模的确证性试验,以填补这一关键知识空白。